Result of EGM

Evolutec Group PLC
06 July 2007

EVOLUTEC GROUP PLC (the 'Company')



6 July 2007



   Results of Extraordinary General Meeting ('EGM') and changes to the Board



At today's EGM a resolution to adjourn the meeting was not passed and as a
consequence, and as anticipated by the Board in its letter to shareholders dated
2 July 2007, the Resolutions to approve the voluntary winding up of the Company
were put to the EGM and were not approved.



As planned, Nicholas Badman, Dr Mark Carnegie Brown, John Burke and Malcolm
Darvell have stood down from the Board with effect from the end of the EGM. Dr
David Bloxham and Graeme Hart will remain on the Board and the Company will
proceed as an investment company with an investment strategy to seek a single
investment, most probably of a UK or European business, in either the
technology, healthcare or service related sectors.



It is expected that the two Directors proposed by Gartmore Investment Limited,
Mark Hawtin and Gordon Hall, will be appointed to the Board shortly.





Enquiries:


Evolutec                                                 0118 922 4480
David Bloxham, Chairman


Numis Securities Limite                                  020 7260 1000
Michael Meade


Financial Dynamics                                       020 7831 3113
David Yates
Ben Brewerton




                      This information is provided by RNS
            The company news service from the London Stock Exchange